7 spine device company powerhouses: What are they up to in 2018?

Written by Megan Wood | May 15, 2018 | Print  |

The global spinal surgery devices market will reach $13 billion by 2022, according to a Wise Guy Reports analysis.

Here are statistics and facts about seven device companies dominating the spine space. Companies are listed in alphabetical order.

DePuy Synthes (Raynham, Mass.)
A part of New Brunswick, N.J.-based Johnson & Johnson, DePuy Synthes saw a 1.1 percent sales growth in the first quarter of 2018, compared to the first quarter of 2017. The company's spine business sales experienced the greatest decline, at 8.9 percent, reaching $804 million. J&J's orthopedic segment dropped to $9.25 billion in 2017 full-year sales, compared to $9.33 billion in 2016.

Here's what the company has been up to in 2018:

  • In April, DePuy Synthes unveiled its PROTI 360° Integrated Titanium Family of interbody devices, intended for patients with degenerative disc disease. 
  • In May, the company entered into an exclusive agreement with Prosidyan to promote the Fibergraft product family for spine fusion surgery.
  • The Institution of Mechanical Engineers recognized DePuy Synthes in February for promoting female engineers. The company's DePuy Synthes' research and development team in Leeds, West Yorkshire, England, is 37 percent female. The national average for female engineers in the U.K. is 11 percent.

Globus Medical (Audubon, Pa.)
For the first quarter of 2018, Globus Medical reported an 11.9 percent increase in global sales to $174.4 million. The company reported $12.8 million in revenue from emerging technologies, partially due to demand for the Company's ExcelsiusGPS robotics navigation system. U.S. spine business grew 4 percent in the first quarter over the first quarter of 2017 on a day-adjusted basis. Globus plans to invest in imaging, navigations, robotics and trauma in the future. The company saw global sales of $636 million in 2017.

Here's what the company has been up to in 2018:

  • In April, the company introduced Elsa AL and Elsa-ATP, two expandable interbody spacers with screw fixation.
  • In May, Globus entered a licensing and distribution agreement with Fovia, combining Fovia's XStream HDVR with Globus Medical's ExcelsiusGPS.
  • Globus Medical, alongside other spine device companies, is collaborating with the Scoliosis Research Society, International Spine Study Group Foundation to complete the Adult Symptomatic Lumbar Scoliosis II study.

K2M (Leesburg, Va.)
K2M's 2018 first quarter revenues increased 10 percent year-over-year, hitting $67.88 million. The U.S. complex spine business saw an 8 percent growth year-over-year. In the first quarter of 2018, the segment brought in $18.51 million in revenue. The company's minimally invasive segment grew to $8.38 million in the first quarter of 2018. K2M reported 2017 revenue of $258 million.

Here's what the company has been up to in 2018:

  • K2M entered in a compatibility and co-marketing agreement with Brainlab in 2017. The companies are still planning a commercial launch in the second half of 2018. During the first quarter conference call, K2M CEO Eric Major said, "The engineering teams are working closely on the compatibility of K2M spinal systems and instrumentation with Brainlab's intraoperative imaging guided navigation and imaging platforms."
  • In March, the company launched its Yukon OCT Spinal System, designed to help surgeons restore cervical sagittal balance through posterior fixation.
  • K2M is also collaborating with the Scoliosis Research Society, International Spine Study Group Foundation to complete the Adult Symptomatic Lumbar Scoliosis II study.

Medtronic (Dublin, Ireland)
Medtronic reported third quarter 2018 revenue of $7.3 billion. The company's spine revenue reached $661 million, increasing 1 percent. Medtronic reported $7.4 billion in sales for fiscal year 2017.

Here's what the company has been up to in 2018:

  • This year, Medtronic took over global commercial responsibility for Mazor X installation.
  • Medtronic continues to push for more outcome-based contracts. The company is signing contracts with customers to adjust prices based on how well the specific product works rather than having a customer paying a fixed price for a product despite its performance.
  • In May, the company revealed its SynergyTLIF(SM) workflow for minimally invasive spine surgery as well as its TiONIC Technology, a titanium 3-D printed platform for spinal implants
  • Medtronic named Chris Lee president of the Asia-Pacific region in January and appointed Laura Mauri, MD, its new vice president of global clinical research and analytics in April.
  • Medtronic is another spine company collaborating with the Scoliosis Research Society, International Spine Study Group Foundation to complete the Adult Symptomatic Lumbar Scoliosis II study. 
  • Medtronic presented a plan to restructure the company in January, hoping it will result in result in $3 billion-plus in annual growth savings by the end of fiscal year 2022.

NuVasive (San Diego)
NuVasive saw 2018 first quarter revenues increase 4.6 percent year-over-year to $260.5 million. However, the company reported a $27.1 million net loss for the quarter, mostly due to litigation liability totaling $29 million related to an ongoing lawsuit. The company's full-year 2017 revenue hit $1.03 billion.

Here's what the company has been up to in 2018:

  • NuVasive launched its Coalesce Thoracolumbar Interbody Fusion Device in January and received expanded FDA clearance for Coalesce and its Cohere Cervical Interbody Fusion Device.
  • In February, CMS designated NuVasive's SpineTRACK Registry as a qualified clinical data registry for the 2018 Merit-based Incentive Payment System reporting year.
  • In April, NuVasive unveiled Anterior Lumbar Interbody Fusion Access, its first Maximum Access Surgery ALIF retractor platform for both lateral and supine spine surgery.
  • In May, the company revealed its Magec X for early onset scoliosis treatment.
  • During the first quarter conference call, NuVasive CEO Gregory Lucier discussed the company's focus on outpatient spine and biologics, and why the company will not dive into the robotics business.
  • NuVasive is also collaborating with the Scoliosis Research Society, International Spine Study Group Foundation to complete the Adult Symptomatic Lumbar Scoliosis II study.

Stryker (Kalamazoo, Mich.)
Stryker reported net sales increased 9.7 percent year-over-year, generating $3.2 billion. The company's orthopedic segment jumped 7.1 percent in sales year-over-year. Stryker's neurotechnology and spine segment experienced the largest growth; net sales totaled $600 million for the quarter. Stryker's 2017 full-year net sales increased 9.9 percent to $12.4 billion. Neurotechnology and spine sales grew 8.2 percent to $2.1 billion.

Here's what the company has been up to in 2018:

  • In February, Stryker achieved 95 percent ownership of Vexim. Stryker completed its $662 million acquisition of Entellus Medical in March.
  • In March, the company reported 311 surgeons had implanted its Tritanium C Anterior Cervical Cage since launch in October 2017.
  • Also in March, the FDA granted clearance for its Tritanium TL Curved Posterior Lumbar Cage.
  • In May, Stryker acquired Hygia Health Services, a developer of single-use devices, to help hospitals reduce costs.
  • Stryker's Group President of Global Quality and Business Operation Lonny Carpenter plans to retire March 31, 2019. Mr. Carpenter ends a 30-year career at Stryker.

Zimmer Biomet (Warsaw, Ind.)
Zimmer Biomet saw $2 billion-plus in net sales in the first quarter of 2018. The company's spine segment sales reached about $183 million for the quarter, a decrease of 1.7 percent year-over-year. The company reported $7.82 billion in full-year 2017 sales.

Here's what the company has been up to in 2018:

  • Zimmer Biomet CEO Bryan Hanson commented on the company's sales decline in the first quarter conference call: "Broadly speaking, I want to emphasize that although we are currently seeing negative year-over-year sales growth, we do expect to accelerate our topline performance to market growth rates or better over the next 18 to 24 months."
  • In March, Zimmer Biomet signed an agreement with the U.S. Department of Energy to join its Better Buildings, Better Plants program; the company committed to reducing its energy intensity by 25 percent over the next 10 years.
  • In April, the company partnered with Warsaw (Ind.) Community Schools to continue expanding STEM initiatives.
  • Zimmer Biomet is also partnering with the Scoliosis Research Society, International Spine Study Group Foundation to complete the Adult Symptomatic Lumbar Scoliosis II study.

More articles on devices:
DePuy Synthes signs agreement to acquire impactor developer: 5 insights
OrthoPediatrics receives FDA clearance for 25th surgical system: 3 insights
3M warming system in hot water over allegedly causing joint infections: 5 takeaways

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months